doi:10.3389/fphar.2022.954938 Sobenin IA, Myasoedova VA, Iltchuk MI, Zhang DW, Orekhov AN
Understanding the practical differences between these injection locationsincluding comfort, accessibility, and proper techniquehelps patients optimise their treatment experience whilst maintaining the essential practice of regular site rotation to minimise injection site reactions

Dietary modifications can substantially reduce diarrhea symptoms: Eat smaller, more frequent meals rather than large portions Reduce intake of high-fat, greasy, or fried foods, which are harder to digest with delayed gastric emptying Limit foods known to trigger diarrhea, including caffeine, alcohol, artificial sweeteners, and spicy foods Increase soluble fiber intake gradually (oats, bananas, applesauce) while avoiding excessive insoluble fiber during acute symptoms Stay well-hydrated with water and electrolyte-containing beverages Symptomatic management may include over-the-counter antidiarrheal medications such as loperamide (Imodium), though patients should consult their healthcare provider before starting these agents
There is no direct pharmacokinetic interaction between semaglutide or tirzepatide and amphetamine salts (Adderall)
Glycemic category (normoglycemia, prediabetes or type 2 diabetes) was determined by investigators on the basis of available information (for example, medical records, concomitant medication, and blood glucose variables) and in accordance with American Diabetes Association criteria 30 , which for prediabetes includes fasting plasma glucose levels of 100 mg dl 1 (5.6 mmol l 1 ) to 125 mg dl 1 (6.9 mmol l 1 ) or HbA 1c levels of 5.76.4% (3947 mmol l 1 ), and for type 2 diabetes includes fasting plasma glucose levels of 126 mg dl 1 (7.0 mmol l 1 ) or HbA 1c levels 6.5% (48 mmol l 1 )
These differences are reviewed by the FDA to ensure they dont impact safety or how the drug works